Molecular prognostic factors for breast cancer metastasis and survival

This publication has 58 references indexed in Scilit:

• Estrogen receptor and breast cancer
  Seminars in Cancer Biology, 2001
• Prognostic significance of oestrogen receptor β in breast cancer
  British Journal of Surgery, 2000
• Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study
  International Journal of Cancer, 2000
• ADJUVANT SYSTEMIC THERAPY FOR PRIMARY BREAST CANCER
  Surgical Clinics of North America, 1999
• Tamoxifen for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• Tumor-related prognostic factors for breast cancer
  CA: A Cancer Journal for Clinicians, 1997
• Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), Insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• How To Use Prognostic Factors in Axillary Node-Negative Breast Cancer Patients
  JNCI Journal of the National Cancer Institute, 1990
• Survival with breast cancer: the importance of estrogen receptor quantity
  European Journal of Cancer and Clinical Oncology, 1989
• Tumor nuclear grade, estrogen receptor, and progesterone receptor: Their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer
  Breast Cancer Research and Treatment, 1986